Unknown

Dataset Information

0

Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide.


ABSTRACT: Most forms of castration-resistant prostate cancer (CRPC) are dependent on the androgen receptor (AR) for survival. While, enzalutamide provides a substantial survival benefit, it is not curative and many patients develop resistance to therapy. Although not yet fully understood, resistance can develop through a number of mechanisms, such as AR copy number gain, the generation of splice variants such as AR-V7 and mutations within the ligand binding domain (LBD) of the AR. circular RNAs (circRNAs) are a novel type of non-coding RNA, which can regulate the function of miRNA, and may play a key role in the development of drug resistance. circRNAs are highly resistant to degradation, are detectable in plasma and, therefore may serve a role as clinical biomarkers. In this study, AR-V7 expression was assessed in an isogenic model of enzalutamide resistance. The model consisted of age matched control cells and two sub-line clones displaying varied resistance to enzalutamide. circRNA profiling was performed on the panel using a high throughout microarray assay. Bioinformatic analysis identified a number of differentially expressed circRNAs and predicted five miRNA binding sites for each circRNA. miRNAs were stratified based on known associations with prostate cancer, and targets were validated using qPCR. Overall, circRNAs were more often down regulated in resistant cell lines compared with control (588 vs. 278). Of particular interest was hsa_circ_0004870, which was down-regulated in enzalutamide resistant cells (p???0.05, vs. sensitive cells), decreased in cells that highly express AR (p???0.01, vs. AR negative), and decreased in malignant cells (p???0.01, vs. benign). The associated parental gene was identified as RBM39, a member of the U2AF65 family of proteins. Both genes were down-regulated in resistant cells (p?

SUBMITTER: Greene J 

PROVIDER: S-EPMC6656767 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide.

Greene John J   Baird Anne-Marie AM   Casey Orla O   Brady Lauren L   Blackshields Gordon G   Lim Marvin M   O'Brien Odharnaith O   Gray Steven G SG   McDermott Raymond R   Finn Stephen P SP  

Scientific reports 20190724 1


Most forms of castration-resistant prostate cancer (CRPC) are dependent on the androgen receptor (AR) for survival. While, enzalutamide provides a substantial survival benefit, it is not curative and many patients develop resistance to therapy. Although not yet fully understood, resistance can develop through a number of mechanisms, such as AR copy number gain, the generation of splice variants such as AR-V7 and mutations within the ligand binding domain (LBD) of the AR. circular RNAs (circRNAs)  ...[more]

Similar Datasets

| S-EPMC7647044 | biostudies-literature
| S-EPMC6424894 | biostudies-literature
| S-EPMC8448594 | biostudies-literature
| S-EPMC8227141 | biostudies-literature
| S-EPMC7598922 | biostudies-literature
| S-EPMC5842852 | biostudies-literature
| S-EPMC4381591 | biostudies-literature
| S-EPMC5122410 | biostudies-literature
| S-EPMC8248110 | biostudies-literature
| S-EPMC6215909 | biostudies-other